Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis

Human Pathology

Volumn 30, Issue 9, 1999, Pages 1097-1105

  Loro, Lado Lako ^a,b   Vintermyr, Olav Karsten ^a   Liavaag, Per Gunnar ^a   Jonsson, Roland ^a   Johannessen, Anne Christine ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Apoptosis; bax; bcl 2; Oral squamous cell carcinoma

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 0032887214     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90229-0     Document Type: Article

References (48)

1. Parkin DM, Läärä E, Muir CS: Estimates of the world-wide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-197, 1988
2. Johnson NW: A global view of the epidemiology of oral cancer, in Oral Cancer (ed 1). Vol 2: Risk Markers for Oral Diseases. Cambridge, United Kingdom, Cambridge University Press, 1991, pp 3-26
3. Lucas RB: Epidermoid tumours, in Pathology of Tumours of the Oral Tissues (ed 4). Edinburgh, Scotland, Churchill Livingstone, 1984, pp 120-150
4. Carson DA, Ribeiro JM: Apoptosis and disease. Lancet 341: 1251-1254, 1993
5. Wyllie AH: The genetic regulation of apoptosis. Curr Opin Genet Dev 5:97-104, 1995
6. Adams JM, Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science 281:1309-1312, 1998
7. Strasser A, Huang DCS, Vaux DL: The role of the bcl-2/ ced-9 gene family in cancer and the general implications in cell death control for tumorigenesis and resistance to chemotherapy. Biochim Biophys Acta 1333:F151-F178, 1997
8. Tsujimoto Y, Cossman J, Jaffe E, et al: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443, 1985
9. Krajewski S, Tanaka S, Takayama S, et al: Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714, 1993
10. Zha H, Aimé-Sempé C, Sato T, et al: Proapoptotic protein bax heterodimerizes with bcl-2 and homodimerizes with bax via a novel domain (BH3) distinct form BHl1and BH2. J Biol Chem 271:7440-7444, 1996
11. Pena JC, Thompson CB, Recant W, et al: Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck. Cancer 85:164-170, 1999
12. Krajewska M, Krajewski S, Epstein JI, et al: Immunohistochemical analysis of bcl-2, bax, bcl-x, and mcl-1 expression in prostate cancers. Am J Pathol 148:1567-1576, 1996
13. Itoh N, Yonehara S, Ishii A, et al: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
14. Speiser DE, Sebzda E, Ohteki T, Bachmann MF, Pfeffer K, Mak TW, Ohashi PS: Tumour necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol 26:3055-3060, 1996
15. Ashkenazi A, Dixit VM: Death receptors: Signaling and modulation. Science 281:1305-1308, 1998
16. Hockenbery DM, Zutter M, Hickey W, et al: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88:6961-6965, 1991
17. Lu Q, Poulsom R, Wong L, et al: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169:431-437, 1993
18. Harada H, Mitsuyasu T, Seta Y, et al: Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro. J Oral Pathol Med 27:11-17, 1998
19. Wilson GD, Grover R, Richman PI, et al: Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy. Anticancer Res 16:2403-2408, 1996
20. Ravi D, Nalinakumari, Rajaram RS, et al: Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Lett 105:139-146, 1996
21. Nylander K, Schildt EB, Eriksson M, et al: PCNA, Ki 67, p53, bcl-2 and prognosis in intraoral squamous cell carcinoma of the head and neck. Anal Cell Pathol 14:101-110, 1997
22. Krajewski S, Krajewska M, Shabaik A, et al: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323-1335, 1994
23. Chrysmoli E, Greenspan JS, Dekker N, et al: Apoptosis-associated proteins in oral hairy leukoplakia. Oral Dis 2:279-284, 1996
24. Jordan RCK, Catzavelos GC, Barrett AW, et al: Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Oral Oncol Eur J Cancer 32B:394-400, 1996
25. Sap JP, Eversole LR, Wysocki GP: Contemporary Oral Pathology. St Louis, MO, Mosby-Year Book, 1997, pp 177-179
26. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
27. Gavrieli Y, Sherman Y, Ben-Sasson S: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
28. Loro L, Vintermyr K, Johannessen AC, et al: Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. J Oral Pathol Med 28:82-87, 1999
29. Koide N, Koike S, Adachi W, et al: Immunohistochemical expression of bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the oesophagus. Surg Today 27:685-691, 1997
30. Verhaegh MEJM, Sanders CJG, Arends JW, et al: Expression of the apoptosis-suppressing protein bcl-2 in non-melanoma skin cancer. Br J Dermatol 132:740-744, 1995
31. Nakopoulou L, Vourlakou C, Zervas A, et al: The prevalence of bcl-2, p53 and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. HUM PATHOL 29:146-154, 1998
32. Pezzella F, Tse A, Cordell J, et al: Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137:225-232, 1990
33. Gerber H, Dixit V, Ferrara N: Vascular endothelial growth factor induces expression of the anti-apoptotic proteins bcl-2 and Al in vascular endothelial cells. J Biol Chem 273:13313-13316, 1998
34. Teixeira C, Reed J, Pratt MA: Estrogen promotes chemotherapeutic drug resistance by a mechanism of involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55:3902-3907, 1995
35. Nakagawa K, Yamamura K, Maeda S, et al: Bcl-2 expression in epidermal keratinocytic diseases. Cancer 74:1720-1724, 1994
36. Wrone-Smith T, Johnson T, Nelson B, et al: Discordant expression of bcl-x and bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 146:1079-1088, 1995
37. Tsujimoto Y, Croce CM: Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved on human follicular lymphoma. Proc Natl Acad Sci U S A 83:5214-5218, 1986
38. Tanaka S, Saito K, Reed JC: Structure-function analysis of the bcl-2 oncoprotein: Addition of a heterologous transmembrane domain to the portion if the bcl-2β protein restores function as a regulator of cell survival. J Biol Chem 268:10920-10926, 1993
39. Cheng E, Kirsch D, Clem R, et al: Conversion of bcl-2 into a bax-like death effector by caspases. Science 278:1966-1968, 1997
40. L, an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. Clin Cancer Res 4:577-583, 1998
41. Doi R, Makino T, Adachi H, et al: Pre-operative radio-chemotherapy enhances apoptotic cell death in oral squamous cell carcinoma. J Oral Pathol Med 27:382-387, 1998
42. Fotedar R, Diederich L, Fotedar A: Apoptosis and the cell cycle. Prog Cell Cycle Res 2:147-163, 1996
43. Evans G, Littlewood T: A matter of life and cell death. Science 281:1317-1322, 1998
44. Sarbia M, Bittinger F, Grabellus F, et al: Expression of bax, a pro-apoptotic member of the bcl-2 family, in esophageal squamous cell carcinomas. Int J Cancer 73:508-513, 1997
45. Puglisi F, Loreto C, Panizzo R, et al: Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus. J Clin Pathol 49:456-459, 1996
46. Pruneri G, Pignataro L, Carboni N, et al: Clinical relevance of p53 and bcl-2 protein over-expression in laryngeal squamous cell carcinoma. Int J Cancer (Pred Oncol) 79:263-268, 1998
47. Ohbu M, Saegusa M, Kobayashi N, et al: Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer 79:1287-1293, 1997
48. Costa A, Licitra L, Veneroni S, et al: Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers. Int J Cancer (Pred Oncol) 79:619-623, 1998